Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (521-530 of 1,289) with videos related to

Pageof 129
Sort By:
Urology|November 1, 1995
Loss of HLA class I expression in prostate cancer: implications for immunotherapyR A Blades, P J Keating, L J McWilliam, et al.
Blood|August 1, 1982
Causes of initial remission induction failure in acute myelogenous leukemiaE H Estey, M J Keating, K B McCredie, et al.
Leukemia & Lymphoma|January 1, 1993
Treatment of Waldenstrom's macroglobulinemia with nucleoside analoguesM A Dimopoulos, S O'Brien, H Kantarjian, et al.
Leukemia|May 27, 2006
Granulocyte colony stimulating factor administration associated with cerebral hemorrhage in acute promyelocytic leukemiaA-M Tsimberidou, E Estey, H Kantarjian, et al.
Human Immunology|March 24, 2005
Indels and imperfect duplication have driven the evolution of human Complement Receptor 1 (CR1) and CR1-like from their precursor CR1 alpha: importance of functional setsC A McLure, J F Williamson, B J Stewart, et al.
Blood|February 3, 2009
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cellsClaudia P Miller, Sharmistha Rudra, Michael J Keating, et al.
Nature|August 23, 1990
Obligatory wounding requirement for tumorigenesis in v-jun transgenic miceA C Schuh, S J Keating, F S Monteclaro, et al.
Neurology|April 1, 1987
Central nervous system complications of a newly recognized subtype of leukemia: AMML with a pericentric inversion of chromosome 16J P Glass, P Van Tassel, M J Keating, et al.
Blood|May 1, 1987
Clinical investigation of human alpha interferon in chronic myelogenous leukemiaM Talpaz, H M Kantarjian, K B McCredie, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2015
Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemiaPaolo Strati, Lynne V Abruzzo, William G Wierda, et al.
Pageof 129

Showing results (521-530 of 1,289) with videos related to

Sort By:
Pageof 129
Urology|November 1, 1995
Loss of HLA class I expression in prostate cancer: implications for immunotherapyR A Blades, P J Keating, L J McWilliam, et al.
Blood|August 1, 1982
Causes of initial remission induction failure in acute myelogenous leukemiaE H Estey, M J Keating, K B McCredie, et al.
Leukemia & Lymphoma|January 1, 1993
Treatment of Waldenstrom's macroglobulinemia with nucleoside analoguesM A Dimopoulos, S O'Brien, H Kantarjian, et al.
Leukemia|May 27, 2006
Granulocyte colony stimulating factor administration associated with cerebral hemorrhage in acute promyelocytic leukemiaA-M Tsimberidou, E Estey, H Kantarjian, et al.
Human Immunology|March 24, 2005
Indels and imperfect duplication have driven the evolution of human Complement Receptor 1 (CR1) and CR1-like from their precursor CR1 alpha: importance of functional setsC A McLure, J F Williamson, B J Stewart, et al.
Blood|February 3, 2009
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cellsClaudia P Miller, Sharmistha Rudra, Michael J Keating, et al.
Nature|August 23, 1990
Obligatory wounding requirement for tumorigenesis in v-jun transgenic miceA C Schuh, S J Keating, F S Monteclaro, et al.
Neurology|April 1, 1987
Central nervous system complications of a newly recognized subtype of leukemia: AMML with a pericentric inversion of chromosome 16J P Glass, P Van Tassel, M J Keating, et al.
Blood|May 1, 1987
Clinical investigation of human alpha interferon in chronic myelogenous leukemiaM Talpaz, H M Kantarjian, K B McCredie, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2015
Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemiaPaolo Strati, Lynne V Abruzzo, William G Wierda, et al.
Pageof 129